Understanding Atrial Fibrillation: What AFib Is and How It Affects the Heart
Atrial fibrillation, commonly called AFib, is a condition where the upper chambers of the heart, called the atria, beat irregularly and often too fast. In a normal heart, electrical signals move in an orderly way through the heart muscle, causing it to beat at a steady rhythm. When someone has AFib, these electrical signals become chaotic, causing the atria to quiver or fibrillate instead of beating properly. This irregular heartbeat can feel like a flutter, racing sensation, or pounding in the chest.
Learn How to Change Your T-Mobile Phone Number →
AFib affects approximately 2.7 to 6.1 million people in the United States, making it one of the most common heart rhythm disorders. The condition becomes more common as people age, with rates increasing significantly after age 65. However, AFib can develop in younger people, particularly those with certain risk factors or underlying heart conditions.
When the atria do not beat effectively, blood can pool inside the heart chambers. This pooled blood may form clots, which is one of the serious complications of untreated AFib. Additionally, when the heart's rhythm becomes erratic, the heart may not pump blood efficiently to the rest of the body, potentially causing symptoms like fatigue, shortness of breath, and dizziness. Some people with AFib have no symptoms at all and only discover the condition during a routine medical examination.
Medical professionals categorize AFib into different types based on pattern and duration. Paroxysmal AFib comes and goes, with episodes lasting from minutes to hours before the heart returns to normal rhythm on its own. Persistent AFib lasts longer than seven days and does not stop without treatment. Permanent AFib means the irregular rhythm is continuous, and attempts to restore normal rhythm have either failed or are not being pursued. Long-standing persistent AFib continues for more than one year. Understanding which type someone has helps guide treatment decisions.
Practical Takeaway: Learning about how AFib develops and the different patterns it can take provides foundation knowledge for discussing treatment options with healthcare providers. Recognizing symptoms like heart palpitations, fatigue, and shortness of breath may prompt someone to seek medical evaluation sooner.
Risk Factors and Causes: Who Develops AFib and Why
Several factors increase the likelihood that someone will develop atrial fibrillation. Age is one of the strongest risk factors—AFib becomes increasingly common after age 60, and the risk roughly doubles with each decade of age. Men develop AFib more frequently than women, though women who do develop it tend to have more severe symptoms and complications.
Free Guide to Understanding Salvage Titles for Vehicles →
High blood pressure (hypertension) is one of the most common modifiable risk factors for AFib. When blood pressure remains elevated over time, it causes the heart muscle to thicken and become stiffer, creating an environment where irregular rhythms develop more easily. Approximately 75 percent of people with AFib have a history of high blood pressure. Other heart conditions also substantially increase AFib risk, including heart failure, valve disease, and coronary artery disease. A previous heart attack can damage the heart muscle in ways that predispose it to developing irregular rhythms.
Lifestyle and health factors play significant roles. Obesity, excessive alcohol consumption, and smoking all contribute to AFib development. Notably, even moderate increases in weight gain can raise AFib risk, and studies show that weight loss may help reduce symptoms in some people. Thyroid disorders, particularly an overactive thyroid (hyperthyroidism), can trigger AFib by speeding up metabolism and heart rate. Sleep apnea, a condition where breathing repeatedly stops and starts during sleep, is also strongly associated with AFib development.
Chronic lung disease, diabetes, chronic kidney disease, and a family history of AFib also increase risk. Some people develop AFib after major surgery or during acute illnesses like pneumonia or sepsis. Certain medications can trigger AFib as a side effect, and some people develop the condition without any identifiable cause, a situation doctors call lone AFib. Understanding personal risk factors can help guide conversations with healthcare providers about prevention strategies and monitoring.
Practical Takeaway: Identifying which risk factors apply to your situation helps inform prevention discussions with your doctor. Many modifiable factors—like blood pressure control, weight management, limiting alcohol, and addressing sleep apnea—may reduce AFib development risk or severity.
Current Guidelines for AFib Diagnosis and Evaluation
Major medical organizations, including the American Heart Association, American College of Cardiology, and Heart Rhythm Society, publish guidelines that help healthcare providers diagnose and evaluate AFib. These guidelines reflect current medical research and expert consensus on best practices. The diagnosis process typically begins with a patient describing symptoms and a medical history, followed by a physical examination where a provider listens to the heart and checks the pulse.
Learn What AAA Auto Insurance Covers for Rentals →
The electrocardiogram (EKG or ECG) is the primary tool for diagnosing AFib. This simple test records the heart's electrical activity and shows whether the rhythm is irregular. During an EKG, small adhesive patches called electrodes are placed on the chest, and wires connect these patches to a machine that records the heart's electrical patterns. The test takes just a few minutes and is painless. An EKG can show whether someone is in AFib at the moment of testing, but since AFib can be intermittent, a single normal EKG does not rule out the condition.
For people with paroxysmal AFib that comes and goes, doctors may recommend extended monitoring devices. A Holter monitor is a portable EKG device worn for 24 to 48 hours that continuously records heart rhythm. An event monitor can be worn for days or weeks and records only when the patient activates it or when it automatically detects irregular rhythms. More advanced monitors, like implantable loop recorders, can track heart rhythm for up to three years. These extended monitoring tools increase the chances of catching irregular episodes that might be missed on a single office EKG.
Guidelines also recommend an echocardiogram for most people newly diagnosed with AFib. This ultrasound test uses sound waves to create images of the heart's structure and function. It shows the size and thickness of the heart chambers, how well the heart pumps, and whether valve disease or other structural problems are present. Blood tests checking thyroid function and other markers help rule out conditions that might cause or contribute to AFib. Guidelines suggest assessing stroke risk using standardized scoring systems that consider factors like age, high blood pressure, diabetes, and previous stroke.
Practical Takeaway: Understanding the diagnostic process—from initial symptoms through monitoring and imaging—helps you know what to expect during medical evaluation. Multiple tests may be needed to fully characterize AFib and identify any underlying conditions requiring treatment.
Stroke Risk and Prevention Strategies in AFib Management
One of the most serious potential complications of AFib is stroke. When the atria do not beat effectively, blood pools inside the left atrial appendage, a small pouch-like structure. This pooled blood can form clots, which may then travel to the brain and cause a stroke. People with AFib have approximately four to five times higher stroke risk compared to people without AFib. Notably, AFib-related strokes tend to be more severe than strokes from other causes, resulting in greater disability and longer recovery periods.
Learn About Diabetes Device Trials Near You →
Healthcare guidelines recommend assessing individual stroke risk using the CHA2DS2-VASc score, a scoring system that assigns points based on various factors. Points are given for congestive heart failure, high blood pressure, age 75 or older, diabetes, previous stroke or blood clots, vascular disease, age 65-74, and female sex. Based on this score, doctors classify patients into risk categories ranging from low to high. The higher the score, the greater the benefit from taking a blood thinner medication to prevent clots.
Blood thinning medications, also called anticoagulants, are the primary tool for stroke prevention in AFib. For many decades, warfarin (Coumadin) was the only available oral anticoagulant. Warfarin requires regular blood tests and dietary consistency since certain foods affect its action. Newer anticoagulants called direct oral anticoagulants (DOACs) have become available in recent years, including apixaban (Eliquat), rivaroxaban (Xarelto), edoxaban (Savaysa), and dabigatran (Pradaxa). These newer medications do not require regular blood testing and tend to have fewer food interactions than warfarin.
Guidelines emphas